Evidence map›Paper›PMID 31007573›Full record

ArticleEuropean journal of organic chemistry2019

Convenient Entry to

E Johanna L Stéen, Vladimir Shalgunov, Christoph Denk, Hannes Mikula, Andreas Kjær, Jesper L Kristensen, Matthias M Herth

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of organic chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Direct Cu-mediated aromaticChemical science · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

E Johanna L StéenDepartment of Drug Design and Pharmacology University of Copenhagen Universitetsparken 2 DK-2100 Copenhagen Denmark.ORCID 0000-0002-8707-7574
Vladimir ShalgunovDepartment of Drug Design and Pharmacology University of Copenhagen Universitetsparken 2 DK-2100 Copenhagen Denmark.ORCID 0000-0001-8956-1207
Christoph DenkInstitute of Applied Synthetic Chemistry Technische Universität Wien Vienna Austria.ORCID 0000-0002-2328-542X
Hannes MikulaInstitute of Applied Synthetic Chemistry Technische Universität Wien Vienna Austria.ORCID 0000-0002-9218-9722
Andreas KjærDepartment of Clinical Physiology Nuclear Medicine and PET University Hospital Copenhagen Copenhagen Denmark.ORCID 0000-0002-2706-5547
Jesper L KristensenDepartment of Drug Design and Pharmacology University of Copenhagen Universitetsparken 2 DK-2100 Copenhagen Denmark.ORCID 0000-0002-5613-1267
Matthias M HerthDepartment of Drug Design and Pharmacology University of Copenhagen Universitetsparken 2 DK-2100 Copenhagen Denmark.ORCID 0000-0002-7788-513X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorine-18 possesses outstanding decay characteristics for positron emission tomography (PET) imaging. Therefore, it is ideally suited for clinical applications. As such, improved strategies to incorporate fluorine-18 into bioactive molecules are of utmost importance. Indirect

Indexed as

AminesAzidesFluorineRadiochemistryReduction

Identifiers

PMID31007573
PMCPMC6471115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.